Results

Total Results: 749 records

Showing results for "features".
Users also searched for: quality measures

101. Draft - Primary Hypofractionated Radiation Therapy for Localized Prostate Cancer: Appendix D1 Tables (xls file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/hypofractionated-radiation-therapy-draft-appendix-d1.xlsx
     January 01, 2024 - Italy Urban Single Histological proof of prostate adenocarcinoma of not more than 6 months; high-risk features … ADT); no previous prostate surgery including transurethral resection; and most importantly, high risk features … antigen (iPSA) of 10-20 ng/mL, or >=3 biopsy cores with Gleason scores $ 5 and without any high-risk features

102. Evidence-based Practice Center Technical Brief Protocol: Disparities and Barriers for Pediatric Cancer Survivorship Care (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/pediatric-cancer-survivorship-protocol.pdf
     June 01, 2020 - survivors of adult cancer as a starting point to develop the framework.9 The framework includes dynamic features … We will highlight the features of the existing and forthcoming research relevant to disparities and … of the technology/intervention, how it works, how it is currently used or might be used, and which features

103. EHC Research Protocol (Amended): Treatments for Acute Episodic Migraine (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/migraine-treatments-research-amended-protocol.pdf
     January 09, 2020 - Data Synthesis - We will qualitatively summarize key features/characteristics (e.g. study populations … comparators), outcomes (e.g., use of unvalidated or nonstandardized outcomes), settings, and study design features … Barriers to the diagnosis and treatment of migraine: effects of sex, income, and headache features.

104. PowerPoint Presentation
     effectivehealthcare.ahrq.gov/sites/default/files/facilitation-webcast-slides.pptx
     June 13, 2013 - (next slide) 8 Be consistent with features of the session Facilitator takes into account… Complexity … Before I turn this over to Ela, I want to alert you to the fact that there are features of the deliberative

105. Methods Guide Atkins (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/methods_guide_atkins.pdf
     January 01, 2011 - angioplasty used the type of drug eluting stent that is currently used in practice.15 Specific product and features … Finally, intervention features may affect the ability to generalize the effectiveness or safety of the … Note whether studies share features that limit applicability—for example, did all the studies exclude … Where studies vary in important features, inspect whether this variation is associated with differences

106. Methods-Guidance-Applicability Methods (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/methods-guidance-applicability_methods.pdf
     January 01, 2011 - angioplasty used the type of drug eluting stent that is currently used in practice.15 Specific product and features … Finally, intervention features may affect the ability to generalize the effectiveness or safety of the … Note whether studies share features that limit applicability—for example, did all the studies exclude … Where studies vary in important features, inspect whether this variation is associated with differences

107. Methods Guide for Comparative Effectiveness Reviews_Inclusion of Nonrandomized Studies of Interventions in Systematic Reviews of Intervention Effectiveness: An Update (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/wysiwyg/pdf/methods-guide-inclusion-nonrandomized-studies.pdf
     September 01, 2022 - We describe the strengths and limitations of RCTs, study design features and types of NRSIs, and key … TYPES OF NRSIS AND STUDY DESIGN FEATURES ............................................................ … Types of NRSIs and Study Design Features Types of NRSIs Unfortunately, there is no consensus on … Every attempt is made to emulate the features of the targeted RCT, except that randomization is not … Specify study design methods or features eligible for the SR. 7.

108. Methods Guide for Comparative Effectiveness Reviews_Inclusion of Nonrandomized Studies of Interventions in Systematic Reviews of Intervention Effectiveness: An Update (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/product/pdf/methods-guide-inclusion-nonrandomized-studies.pdf
     September 01, 2022 - We describe the strengths and limitations of RCTs, study design features and types of NRSIs, and key … TYPES OF NRSIS AND STUDY DESIGN FEATURES ............................................................ … Types of NRSIs and Study Design Features Types of NRSIs Unfortunately, there is no consensus on … Every attempt is made to emulate the features of the targeted RCT, except that randomization is not … Specify study design methods or features eligible for the SR. 7.

109. Postpartum Care for Women Up to One Year After Pregnancy (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/product/pdf/postpartum-care-one-year-protocol-amendment.pdf
     April 25, 2022 - occurring around the time of giving birth (e.g., for postpartum hemorrhage, preeclampsia with severe features … For each study, we will extract publication identifying data, study design features, population characteristics … study included in the SR will be described in summary and evidence tables presenting study design features … We will detail these features in evidence tables and summarize them in the text of the Report to allow

110. March 3rd Impact of Healthcare Algorithms on Racial and Ethnic Disparities in Healthcare (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/wysiwyg/impact-healthcare-algorithms-racial-ethnic-disparities-March-3.pdf
     July 01, 2023 - Measurement bias Bias due to differences in how features are measured across subgroups. … F2.1) Reassess the system design, including the choice of training data, features, objective function … F3.5} Reassess the system design. including the choice of training data, features, objective function

111. Research Protocol: Disparities Within Serious Mental Illness (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/mental-illness-disparities_research-protocol.pdf
     July 01, 2015 - This multidisciplinary database features full text for more than 4,000 journals with many dating back … Care”[MeSH] 261245 #4 Search (“Mood Disorders”[Mesh] OR “Schizophrenia and Disorders with Psychotic Features … of the technology/intervention, how it works, how it is currently used or might be used, and which features

112. Topic Brief: Nonpharmacologic Treatment of Mental Health Conditions in Pregnant and Postpartum People (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/nt_docs/1002-nonpharmacologic-treatment-topic-brief.pdf
     June 03, 2024 - The prevalence of PTSD in pregnancy ranges from 4-6%. 1 https://www.cdc.gov/reproductivehealth/features … effectivehealthcare.ahrq.gov/get-involved/nominated-topics/non-pharmacologic-treatments https://www.cdc.gov/reproductivehealth/features … are many interventions, and guidance is not available. 2 https://www.cdc.gov/reproductivehealth/features … /maternal-depression/index.html https://www.cdc.gov/reproductivehealth/features/maternal-depression

113. ambulatory-safety-protocol-150724 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/ambulatory-safety_research-protocol.pdf
     July 24, 2015 - of the technology/intervention, how it works, how it is currently used or might be used, and which features

114. Han (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/han.pdf
     December 26, 2012 - Inconsistent  findings, reproducibility o Conflicting expert opinion Slide 10: Complexity • Features

115. Acs-Pci-Adjunctive-Devices Research-Protocol (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/acs-pci-adjunctive-devices_research-protocol.pdf
     July 01, 2010 - Below we describe in more detail the features that will determine the strength of evidence for the different … Applicability PICOTS and data to extract Feature Condition that limits applicability Features to be

116. Nonsurgical Treatments for Urinary Incontinence in Adult Women: (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/urinary-incontinence-update_research-protocol.pdf
     June 06, 2017 - analyzed; outcome definitions; effect modifiers; enrolled and analyzed sample sizes; study design features … update will be summarized together in narrative form and in summary tables that tabulate the important features … available, we may also conduct metaregression analyses to evaluate study, patient, and intervention features … Mixed urinary Incontinence: UI with features of both stress and urge UI.

117. Disposition of Comments Report for Interventions To Modify Health Care Provider Adherence to Asthma Guidelines (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/asthma-provider-adherence_disposition-comments.pdf
     May 19, 2013 - statement that suggests a multi‐targetted approach might be best to improve overall care and the best features … With those strategies that did show some promise, what were the key features? … However, the objective should indicate how the report is to be used, for example, features useful to … This section should give some direction to future work in this area and features of programs that could

118. Juvenile-Arthritis-Dmards Surveillance (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/juvenile-arthritis-dmards_surveillance.pdf
     March 14, 2013 - safety and efficacy of canakinumab in systemic juvenile idiopathic arthritis with active systemic features … Trial 2- open label treatment with canakinumab 84 Age 2-19, systemic JIA and active systemic features … Trial 2- open label treatment with canakinumab 84 Age 2-19, systemic JIA and active systemic features … trial of canakinumab at 0.5mg/kg, 1.5 mg/kg or 4.5mg/kg 26 Children with JIA and active systemic features … Trial 2- open label treatment with canakinumab 84 Age 2-19, systemic JIA and active systemic features

119. Juvenile-Arthritis-Dmards Surveillance (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/juvenile-arthritis-dmards_surveillance.pdf
     March 14, 2013 - safety and efficacy of canakinumab in systemic juvenile idiopathic arthritis with active systemic features … Trial 2- open label treatment with canakinumab 84 Age 2-19, systemic JIA and active systemic features … Trial 2- open label treatment with canakinumab 84 Age 2-19, systemic JIA and active systemic features … trial of canakinumab at 0.5mg/kg, 1.5 mg/kg or 4.5mg/kg 26 Children with JIA and active systemic features … Trial 2- open label treatment with canakinumab 84 Age 2-19, systemic JIA and active systemic features

120. Disposition of Comments_Comparative Effectiveness Review No. 276: Diagnosis and Managment of Obsessive Compulsive Disorders in Children (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/obsessive-compulsive-disorder-disposition-comments.pdf
     December 06, 2024 - studies [meeting our inclusion criteria] that identified participants with OCD who had concurrent features